- Home
- ERAS vs TACO Comparison
ERAS vs TACO Comparison
Compare ERAS & TACO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- TACO
- Stock Information
- Founded
- ERAS 2018
- TACO 2024
- Country
- ERAS United States
- TACO United States
- Employees
- ERAS N/A
- TACO N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- TACO Blank Checks
- Sector
- ERAS Health Care
- TACO Finance
- Exchange
- ERAS Nasdaq
- TACO Nasdaq
- Market Cap
- ERAS 439.7M
- TACO 393.9M
- IPO Year
- ERAS 2021
- TACO 2025
- Fundamental
- Price
- ERAS $2.44
- TACO $10.60
- Analyst Decision
- ERAS Buy
- TACO
- Analyst Count
- ERAS 6
- TACO 0
- Target Price
- ERAS $3.67
- TACO N/A
- AVG Volume (30 Days)
- ERAS 2.1M
- TACO 100.7K
- Earning Date
- ERAS 11-07-2025
- TACO 01-01-0001
- Dividend Yield
- ERAS N/A
- TACO N/A
- EPS Growth
- ERAS N/A
- TACO N/A
- EPS
- ERAS N/A
- TACO N/A
- Revenue
- ERAS N/A
- TACO N/A
- Revenue This Year
- ERAS N/A
- TACO N/A
- Revenue Next Year
- ERAS N/A
- TACO N/A
- P/E Ratio
- ERAS N/A
- TACO N/A
- Revenue Growth
- ERAS N/A
- TACO N/A
- 52 Week Low
- ERAS $1.01
- TACO $10.20
- 52 Week High
- ERAS $3.31
- TACO $11.32
- Technical
- Relative Strength Index (RSI)
- ERAS 59.41
- TACO N/A
- Support Level
- ERAS $2.18
- TACO N/A
- Resistance Level
- ERAS $2.65
- TACO N/A
- Average True Range (ATR)
- ERAS 0.15
- TACO 0.00
- MACD
- ERAS -0.03
- TACO 0.00
- Stochastic Oscillator
- ERAS 55.79
- TACO 0.00
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.